Hyperthermia: an effective strategy to induce apoptosis in cancer cells
/in Hyperthermia, International Publications /von 2015-11-01 / Apoptosis 2015 Nov;20(11):1411-9Oncolysis by paramyxoviruses: preclinical and clinical studies
/in International Publications, Newcastle Disease Virus /von 2015-10-21 / Mol Ther Oncolytics 2015;2Dendritic cell vaccination with a toll-like receptor agonist derived from mycobacteria enhances anti-tumor immunity
/in Dendritic Cells, International Publications /von 2015-10-20 / Oncotarget 2015 Oct;6(32):33781-90Improving immunological tumor microenvironment using electro-hyperthermia followed by dendritic cell immunotherapy
/in Dendritic Cells, Hyperthermia, International Publications /von 2015-10-15 / BMC Cancer 2015 Oct;15:708Validity of combination active specific immunotherapy for colorectal cancer: a meta-analysis of 2993 patients
/in Colorectal Cancer, International Publications /von 2015-10-09 / Cytotherapy 2015 Dec;17(12):1746-62Oncolytic Newcastle disease virus as a prospective anti-cancer therapy. A biologic agent with potential to break therapy resistance
/in International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2015-10-05 / Expert Opin Biol Ther 2015;15(12):1757-71Dendritic Cells as Pharmacological Tools for Cancer Immunotherapy
/in Dendritic Cells, International Publications /von 2015-10-01 / Pharmacol. Rev. 2015 Oct;67(4):731-53Lenalidomide Synergistically Enhances the Effect of Dendritic Cell Vaccination in a Model of Murine Multiple Myeloma
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2015-10-01 / J. Immunother. 2015 Oct;38(8):330-9Natural and therapy-induced immunosurveillance in breast cancer
/in Breast Cancer, International Publications /von 2015-10-01 / Nat. Med. 2015 Oct;21(10):1128-38
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de